Yahoo Canada Web Search

Search results

  1. Halda means “to hold” in old Nordic languages. It represents the way that Halda’s novel therapeutic mechanism holds two proteins together in a tightly regulated manner, resulting in cancer-targeted loss of a function essential to cell survival.

    • Our Pipeline

      WE ARE ADVANCING OUR FIRST-IN-CLASS ORAL RIPTAC™...

    • Our Science

      At Halda, we are expanding beyond today’s precision oncology...

    • News & Publications

      Learn about the Halda origin story that has led us to...

    • Our Platform

      Halda has built a suite of tools and know-how to discover...

    • Join Us

      Halda is a place where you can embrace your purpose and be...

    • Contact Us

      HALDA THERAPEUTICS. 115 Munson Street, Suite 101, New Haven,...

    • Taking Hold. Conquering Cancer.

      Our RIPTAC therapeutics hold two proteins together: one that...

  2. Aug 12, 2024 · Our RIPTAC therapeutics hold two proteins together: one that is tumor-specific and another that performs an essential function. The novel protein-protein interaction results in selective killing of the cancer cell.

  3. Halda is inventing novel precision medicines for oncology. Specifically, we are developing RIPTAC™ therapeutics, a new drug modality for the treatment of cancer.

  4. WE ARE ADVANCING OUR FIRST-IN-CLASS ORAL RIPTACTHERAPEUTICS TO SELECTIVELY KILL CANCER CELLS IN MAJOR TUMOR TYPES. We are leveraging our RIPTAC platform to build a robust pipeline of oral, precision treatments for many cancer types.

  5. Feb 14, 2023 · Halda Therapeutics, a Connecticut-based biotechnology startup co-founded by Yale University cancer researcher and serial entrepreneur Craig Crews, emerged from stealth Tuesday with plans to develop medicines it claims can kill tumors in an unusual way.

    • Ben Fidler
  6. Aug 12, 2024 · Halda Therapeutics is a biotechnology company, founded by Professor Craig Crews from Yale University, that has developed a proprietary RIPTAC™ (Regulated Induced Proximity Targeting Chimeras)...

  7. People also ask

  8. Feb 14, 2023 · Halda Therapeutics is a biotechnology company developing a proprietary RIPTAC ™ (Regulated Induced Proximity TArgeting Chimeras) modality that works by a novel “hold and kill” mechanism for the...

  1. People also search for